Guideline aims to recognize the risks, signs, and symptoms of acute HIV infection and to promote HIV testing in individuals presenting with flu-like symptoms or viral syndromes. It provides recommendations for diagnostic testing, treatment, and prevention services to improve patient health and reduc

0 views • 19 slides

The Global Fund has been supporting HIV, TB, and Malaria programs in India since 2002, with significant grant disbursements. Consultations and meetings have paved the way for allocating funds and determining priorities for the upcoming grant period. The allocation split between NACO and NGPR has bee

0 views • 13 slides

This update highlights key points from the PMK No. 23/2022 on combating HIV, AIDS, and STIs. It covers terminologies, goals for eliminating HIV and AIDS by 2030, and strategies such as PrEP and PEP. The guidelines emphasize timely interventions like Post-Exposure Prophylaxis (PEP) and Pre-Exposure P

3 views • 38 slides

In sub-Saharan Africa, a study was conducted among Lake Victoria fishermen in Kenya to assess the effectiveness of a social network-based intervention in improving HIV testing and linkage outcomes. Results showed significantly higher rates of HIV self-testing and linkage to health facilities in the

0 views • 19 slides

Cardiovascular disease is a growing concern in individuals living with HIV, despite advancements in treatment. The REPRIEVE Trial sheds light on the importance of assessing cardiovascular risk and implementing primary prevention measures in this population. Dr. Grinspoon's financial disclosures and

0 views • 35 slides

Explore essential information on HIV and AIDS, including transmission myths, definitions, the importance of people-first language, and statistics specific to Oklahoma. Learn about the impact of HIV/AIDS in the United States and why accurate understanding and language are crucial in addressing this p

3 views • 35 slides

HIV and AIDS are closely related, with HIV being the virus that leads to AIDS. HIV weakens the immune system by attacking specific white blood cells, while AIDS is the advanced stage of HIV infection. Prevention is crucial as AIDS is a deadly, incurable disease. The transmission of HIV primarily occ

4 views • 14 slides

The REPRIEVE trial focuses on developing a cardiovascular disease prevention strategy for individuals living with HIV. It addresses the increased risk of CVD in this population, even with good viral suppression. The study evaluates the use of pitavastatin, a statin with anti-inflammatory properties,

1 views • 33 slides

Explore how differentiated care is revolutionizing HIV service delivery by shifting the focus to client-centered approaches. Learn about the current challenges in facility-based care, the needs of people living with HIV, best practices from various countries, and innovative ways to provide different

0 views • 8 slides

HIV, a member of the lentivirus subfamily of retroviruses, causes Acquired Immunodeficiency Syndrome (AIDS). HIV-1 and HIV-2 have distinct characteristics, with HIV-1 being global and HIV-2 primarily in West Africa. The virus encodes reverse transcriptase and has an envelope containing glycoproteins

1 views • 31 slides

GLP-1 receptor agonists offer a promising therapeutic approach for weight management in individuals with HIV. Weight gain is a common issue, exacerbated by antiretroviral therapy, and can lead to metabolic risks. This presentation by Dr. Suman Srinivasa discusses the potential of GLP-1 receptor agon

2 views • 32 slides

Communicable Disease Harm Reduction Section collaborated with Simple HealthKit to offer free HIV, syphilis, gonorrhea, chlamydia, and trichomoniasis testing to Wisconsin residents over 18 from August 25, 2023, to October 20, 2023. The aim was to make HIV and STI testing more accessible to those with

0 views • 23 slides

The global AIDS epidemic in 2020 saw 37.7 million adults and children living with HIV, with 1.5 million new infections and 680,000 AIDS-related deaths. Africa remains heavily affected, with 60% of new infections occurring in sub-Saharan Africa. The data highlights the continued challenges in combati

2 views • 11 slides

Combination antiretroviral therapy (ART) is effective against HIV but can lead to drug resistance if not taken consistently. HIV mutates rapidly, increasing the risk of drug-resistant strains emerging. Learn about the causes, types of resistance, testing methods, and prevention strategies to combat

0 views • 23 slides

HIV Post-Exposure Prophylaxis (PEP) is a crucial emergency medical response for individuals exposed to HIV, aiming to prevent infection. It involves a regimen of medications, tests, and counseling services initiated within 72 hours of exposure. HIV transmission occurs through body fluids like blood,

3 views • 27 slides

Human Immunodeficiency Virus (HIV) is a retrovirus causing Acquired Immunodeficiency Syndrome (AIDS). HIV leads to immune system destruction, making individuals vulnerable to opportunistic infections and tumors. Common sexually transmitted diseases like syphilis, chlamydia, and gonorrhea are discuss

5 views • 15 slides

This content provides an overview of the relationship between TB and HIV, emphasizing the importance of testing HIV patients for latent TB infection and TB patients for HIV. It also outlines the guidelines for managing these co-infections, including diagnostic tests, treatment strategies, and patien

0 views • 17 slides

Learning and teaching in Pakistan Studies involve the use of instructional aids such as visual aids, audio aids, and audio-visual aids to enhance the teaching-learning process in schools. These aids help in¡n reinforcing knowledge, stimulating sensory organs, and facilitating quick comprehension fo

0 views • 26 slides

Adventist AIDS International Ministry (AAIM) in Malawi is dedicated to helping those affected by HIV/AIDS through various programs and collaborations. The ministry involves church ministries, collaborations with organizations like ADRA Malawi and the Malawi government, and runs multiple HIV/AIDS pro

4 views • 11 slides

PEPFAR is intensifying efforts on partner notification services for HIV prevention to address the global issue of undiagnosed HIV cases. The initiative aims to improve testing strategies, increase testing volumes, and enhance epidemic control. By reaching HIV testing targets and implementing efficie

0 views • 24 slides

This study led by Dr. Geoffrey Chipungu, an HIV/AIDS Specialist at UNICEF ESARO, explores the rates, trends, and factors associated with HIV viral load suppression (VLS) in children. The research reveals sub-optimal VLS rates in children compared to adults, highlighting the need for improved policie

4 views • 12 slides

Update on advanced HIV disease in South Africa highlights progress in reducing AIDS-related deaths, prevalence rates, and advancements in coordinating and implementing policies and guidelines for HIV/AIDS response. The report covers statistics on HIV prevalence, ART facilities, mortality rates, and

0 views • 17 slides

HIV, Human Immunodeficiency Virus, attacks the immune system and can progress to AIDS if left untreated. Antiretroviral Therapy (ART) helps control HIV, allowing individuals to live healthy lives. The stages of HIV include Acute Infection, Chronic Infection, and the most severe stage, AIDS. Early de

0 views • 29 slides

Incidence of HIV/AIDS in the SADC region has been steadily increasing, with 15 million HIV-positive individuals. Member states have implemented measures at national and regional levels, including multi-sectoral plans and commitments to various frameworks and declarations. Efforts have been made towa

1 views • 32 slides

This content provides detailed instructions for conducting HIV rapid tests using three different kits: Determine HIV-1/2 Rapid Test, Uni-Gold HIV-1/2 Rapid Test, and Bioline HIV-1/2 Rapid Test. The instructions include steps such as specimen collection, test device preparation, result interpretation

0 views • 5 slides

Detailed insights into the Ryan White Part A/MAI clients in the Baltimore EMA area, focusing on client-level data, demographics, housing status, and key statistics from FY2016. The mission and objectives outlined by the BCHD Ryan White HIV/AIDS Bureau to enhance the quality of life for individuals l

0 views • 24 slides

August 18, 2020, marked the 30th anniversary of the Ryan White CARE Act, a landmark legislation that established the Ryan White HIV/AIDS Program providing care and treatment services to individuals with HIV in the U.S. The Act has been amended several times to extend and revise its purpose, no longe

0 views • 21 slides

This presentation by Tim Horn, MS, delves into the effects of drug pricing and generics on Ryan White HIV/AIDS Programs, focusing on cost containment, program income, challenges with antiretroviral drug pricing, and the role of generic drugs in mitigating costs. The discussion also covers the 340B D

0 views • 31 slides

This training session focuses on the relationship between undernutrition and HIV, discussing how HIV/AIDS affects nutrition among People Living with HIV (PLHIV). It covers the benefits of good nutrition for PLHIV and provides recommendations for Nutrition Assessment, Counselling, and Support (NACS)

1 views • 27 slides

Human Immunodeficiency Virus (HIV) is a lentivirus that infects CD4 T lymphocytes, leading to Acquired Immunodeficiency Syndrome (AIDS). Cutaneous manifestations of HIV/AIDS vary depending on the stage of infection and CD4 T cell counts. Early signs include exanthem, oral hairy leukoplakia, candidia

0 views • 17 slides

In response to the HIV/AIDS pandemic, this study focuses on the effectiveness of Pre-Exposure Prophylaxis (PrEP) in reducing HIV transmission among African American men who have sex with men in Orangeburg, SC. The research aims to investigate the impact of PrEP compared to condom use, and the necess

0 views • 6 slides

The AIDS update for Asia and the Pacific region in 2019 reveals concerning statistics on new HIV infections, with a focus on young people and men who have sex with men. The data showcases regional profiles, prevalence rates, and incidence trends, shedding light on the challenges in combating HIV/AID

0 views • 21 slides

Maria, a pregnant woman in Malawi, faces the challenge of an unexpected pregnancy and a positive HIV diagnosis. The scenario explores her concerns, midwifery diagnosis, preparation for HIV testing, disclosure of results, and maintaining confidentiality in antenatal care. It also delves into factors

0 views • 10 slides

12.7 million people worldwide inject drugs, with 1.7 million of them living with HIV. The prevalence of HIV among people who inject drugs is 13.1%, highlighting the need for comprehensive service provision including testing, needle programs, opioid therapy, and antiretroviral treatment. The data als

0 views • 4 slides

This presentation highlights the significance of Regenerating Islet-Derived Protein-3 (REG3) and Intestinal Fatty Acid Binding Protein (I-FABP) in microbial translocation, inflammation, and reservoir size in individuals living with HIV. REG3 and I-FABP serve as markers of gut epithelial damage and p

0 views • 7 slides

The research focuses on the perceptions of rural women in the Vhembe district, Limpopo province, regarding sexual health communication in the context of HIV/AIDS. It highlights the challenges women face due to gender norms, cultural practices, and societal inequalities that contribute to the vulnera

0 views • 15 slides

The Global AIDS Update 2019 provides an overview of the HIV situation in the Caribbean region, including statistics on new HIV infections, AIDS-related deaths, key populations affected, and interventions in place. The data reflects changes in HIV prevalence, incidence, and prevention efforts from 20

0 views • 17 slides

This content provides information on HIV/AIDS prevention, including ways to get HIV, common body fluids transmitting HIV, ways to prevent HIV, and risk reduction strategies. It also includes steps for using a condom and guidelines for handling unsafe behaviors through the SWAT method. The curriculum

0 views • 19 slides

This update provides insights into the HIV/AIDS situation in Latin America from 2000 to 2018, covering aspects such as new infections, AIDS-related deaths, incidence-prevalence ratio, and key population demographics. The data reflects changes in policies, prevalence among key populations like sex wo

0 views • 17 slides

Learn how to identify common therapies used in HIV/AIDS and TB treatment, understand drug-food interactions and side effects, and provide appropriate nutrition assessment and support to improve treatment outcomes. Service providers play a crucial role in addressing nutritional needs and managing dru

0 views • 34 slides